AllPennyStocks.com This MedTech Stock Just Surged 81% on a Distribution Deal You ...

This MedTech Stock Just Surged 81% on a Distribution Deal You Didn't See Coming

This MedTech Stock Just Surged 81% on a Distribution Deal You Didn't See Coming By: Dylan Sikes – AllPennyStocks.com News

Wednesday, January 28, 2026

The home healthcare market continues to expand as patients and caregivers seek reliable medical solutions outside traditional hospital settings. Enteral feeding—delivering nutrition directly to the gastrointestinal tract—represents a critical segment of this market, with millions of Americans relying on tube feeding for daily nutrition and medication delivery. As care increasingly shifts from acute facilities to home environments, demand is growing for accessible, affordable products that maintain clinical standards.

Shares of ENvue Medical, Inc. (NASDAQ: FEED) are soaring Tuesday after the company announced a strategic distribution agreement with U-Deliver to expand nationwide access to its over-the-counter reusable ENFit Syringes through non-acute care channels.

ENvue Medical is a medical technology company specializing in intelligent, non-invasive solutions for enteral care across clinical and home care settings. The company operates two distinct technology platforms: the ENvue Navigation Platform, an FDA 510(k)-cleared electromagnetic navigation system for feeding tube placement, and acoustic-based therapeutic technologies including PainShield and UroShield devices.

Under the agreement, U-Deliver will distribute ENvue's recently launched ENFit syringe line through its digital and wholesale channels, including its website, Amazon storefront, and wholesale distribution network. The syringes are available in 2.5 mL, 5 mL, 10 mL, and 60 mL sizes without a prescription. The products meet ISO 80369-3 global standards and are designed for reuse for up to seven days or 20 uses, supporting safe enteral delivery in both clinical and home care environments.

"We believe that our partnership with U-Deliver is an important step in scaling ENvue's over-the-counter ENFit syringe line and strengthening our presence in the non-acute enteral care market," said Doron Besser, MD, Chief Executive Officer of ENvue Medical. "We're focused on providing patients and caregivers with reliable, safe solutions for feeding and medication delivery, and supporting continuity of care beyond the hospital."

U-Deliver is a U.S.-based supplier focused on enteral feeding supplies for patients and caregivers in home and long-term care settings. The company serves non-acute care customers through online and distribution channels.

"We are excited to partner with ENvue, an organization that shares our mission to make tube feeding easier," said Brian Johnson, President and Co-Founder of U-Deliver. "Through our digital and wholesale channels, we believe we are positioned to broaden access to ENvue's ENFit syringes while delivering the quality and affordability our customers expect."

For ENvue, the partnership represents a commercial expansion beyond its core navigation technology, leveraging an established distribution partner to reach the growing home care market.

Shares of FEED are ahead 81.1% at $1.91.


Copyright © 2026 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Debt Reduction Deal Sends Microcap Soaring
Step-Out Drilling Intersects 22m of 4.24% Copper and 2.16 g/t Gold in Yukon
Critical Minerals Explorer Hits Continuous Oxide in Every Resource Hole
Most Popular
{{ index + 1 }}


Back to Top